CHRDL1 and glaucoma: Since we have shown that CHRDL1 mutations do not lead to increased IOP or glaucoma (Table 1) [3], the repeated examinations that are required to monitor IOP (under anaesthesia) for PCG patients are not required for MGC1 patients.